179 related articles for article (PubMed ID: 22875697)
1. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells.
Wu J; Wang YS; Yang XY; Liu YY; Yang JR; Yang R; Zhang N
Nanotechnology; 2012 Sep; 23(35):355101. PubMed ID: 22875697
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells.
Guo H; Liu Y; Wang Y; Wu J; Yang X; Li R; Wang Y; Zhang N
Carbohydr Polym; 2014 Oct; 111():908-17. PubMed ID: 25037431
[TBL] [Abstract][Full Text] [Related]
3. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
[TBL] [Abstract][Full Text] [Related]
4. Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro.
Zhi F; Dong H; Jia X; Guo W; Lu H; Yang Y; Ju H; Zhang X; Hu Y
PLoS One; 2013; 8(3):e60034. PubMed ID: 23527297
[TBL] [Abstract][Full Text] [Related]
5. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.
Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z
Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799
[TBL] [Abstract][Full Text] [Related]
6. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.
Wang YC; Wang F; Sun TM; Wang J
Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin and chloroquine coencapsulated liposomes: preparation and improved cytotoxicity on human breast cancer cells.
Qiu L; Yao M; Gao M; Zhao Q
J Liposome Res; 2012 Sep; 22(3):245-53. PubMed ID: 22607110
[TBL] [Abstract][Full Text] [Related]
8. Poly(styrene oxide)-poly(ethylene oxide) block copolymers: From "classical" chemotherapeutic nanocarriers to active cell-response inducers.
Cambón A; Rey-Rico A; Barbosa S; Soltero JF; Yeates SG; Brea J; Loza MI; Alvarez-Lorenzo C; Concheiro A; Taboada P; Mosquera V
J Control Release; 2013 Apr; 167(1):68-75. PubMed ID: 23352909
[TBL] [Abstract][Full Text] [Related]
9. PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy.
Wang L; Yu D; Dai R; Fu D; Li W; Guo Z; Cui C; Xu J; Shen S; Ma K
Int J Pharm; 2019 Feb; 557():66-73. PubMed ID: 30580088
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
13. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
14. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
15. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.
Shen J; He Q; Gao Y; Shi J; Li Y
Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492
[TBL] [Abstract][Full Text] [Related]
17. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance.
Feng L; Li K; Shi X; Gao M; Liu J; Liu Z
Adv Healthc Mater; 2014 Aug; 3(8):1261-71. PubMed ID: 24652715
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
Qi X; Chang Z; Song J; Gao G; Shen Z
Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
20. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments.
Bae Y; Nishiyama N; Kataoka K
Bioconjug Chem; 2007; 18(4):1131-9. PubMed ID: 17488066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]